@DHSCgovuk officials are heaping praise upon Jonathan Van-Tam, the deputy chief medical officer who already has something of a cult following in Westminster due to his likeably plain-speaking appearances at the Downing St. #covid19 briefings. (Politico)
1/
Jonathan Van-Tam (JVT as he's become known) is the man who helped set & up/fund the @UniofOxford clinical trials that led to the discovery that Dexamethasone is a effective treatment for serious cases of #covid19. He always comes over as trustworthy.
2/
@bloodcancer_uk Yes, difficulty getting slots, but able to get some click n collect which works well. The supermarket staff put the bags in the boot so there is no contact
UPDATED! Save the date for the Sixth Annual Immunotherapy in #Myeloma Scientific Workshop, which has been moved, and will now occur (COVID-19 permitting) from June 18th to June 20th, 2020, on board the Queen Mary in Long Beach, California. Everyone please stay safe and healthy!
MPE has received a range of queries about the impact that the #COVID19 situation is having on treatment and care. Here is a Q&A on how treatment, hospital appointments and clinical trials may be affected for #myeloma and #ALamyloidosis patients. https://t.co/n7IvKvzSin
Register Now for This IMF Patient & Family Webinar
Join the IMF Patient & Family Webinar on Saturday, May 9, 2020, at 1:00 p.m. PT / 2:00 p.m. MT / 3:00 p.m. CT / 4:00 p.m. ET.
https://t.co/207Rx7XRem
"Blood cancers such as leukemia, lymphoma and myeloma attack the immune system, reducing patients’ natural defenses and making them prone.." https://t.co/BTwddnAhuJ
NEWS 📰 Read the final topline results from the phase II HORIZON study evaluating melflufen for the treatment of patients with R/R multiple #myeloma. The analysis was inclusive of patients with triple-class refractory- and extramedullary disease ➡️ https://t.co/ZCaUw2HxoS #mmsm